Effects of pentamidine isethionate on Saccharomyces cerevisiae.
We used Saccharomyces cerevisiae as a model system in which to examine the mechanism of action of the anti-Pneumocystis drug pentamidine. Pentamidine at low concentrations inhibited S. cerevisiae growth on nonfermentable carbon sources (50% inhibitory concentration [IC50] of 1.25 micrograms/ml in glycerol). Pentamidine inhibited growth on fermentable energy sources only at much higher concentrations (IC50 of 250 micrograms/ml in glucose). Inhibition at low pentamidine concentrations in glycerol was due to cytostatic activity rather than cytotoxic or mutagenic activity. Pentamidine also rapidly inhibited respiration by intact yeast cells, although inhibitory concentrations were much higher than those inhibitory to growth (IC50 of 100 micrograms/ml for respiration). Pentamidine also induced petite mutations, although only at concentrations much higher than those required for growth inhibition. These results suggest that a function essential for respiratory growth is inhibited by pentamidine and that pentamidine affects mitochondrial processes. We propose the hypothesis that the primary cellular target of pentamidine in S. cerevisiae is the mitochondrion.
Ludewig
G
G
T. H. Morgan School of Biological Sciences, University of Kentucky, Lexington 40506-0225.
Williams
J M
JM
Li
Y
Y
Staben
C
C
D005838:Genotype; D007202:Indicators and Reagents; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D016296:Mutagenesis / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D010419:Pentamidine / Q000494:pharmacology*; D012441:Saccharomyces cerevisiae / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism
D007202:Indicators and Reagents; D010419:Pentamidine